| Chromatin environment, transcriptional regulation, and splicing distinguish lincRNAs and mRNAs M Melé, K Mattioli, W Mallard, DM Shechner, C Gerhardinger, JL Rinn Genome research 27 (1), 27-37, 2017 | 244 | 2017 |
| High-throughput functional analysis of lncRNA core promoters elucidates rules governing tissue specificity K Mattioli, PJ Volders, C Gerhardinger, JC Lee, PG Maass, M Melé, ... Genome research 29 (3), 344-355, 2019 | 111 | 2019 |
| Cis and trans effects differentially contribute to the evolution of promoters and enhancers K Mattioli, W Oliveros, C Gerhardinger, D Andergassen, PG Maass, ... Genome biology 21, 1-22, 2020 | 39 | 2020 |
| Resolving mechanisms of immune‐mediated disease in primary CD 4 T cells C Bourges, AF Groff, OS Burren, C Gerhardinger, K Mattioli, A Hutchinson, ... EMBO Molecular Medicine 12 (5), e12112, 2020 | 28 | 2020 |
| Whole genome sequencing delineates regulatory, copy number, and cryptic splice variants in early onset cardiomyopathy R Lesurf, A Said, O Akinrinade, J Breckpot, K Delfosse, T Liu, R Yao, ... NPJ genomic medicine 7 (1), 18, 2022 | 16 | 2022 |
| Genome-wide CRISPR interference screen identifies long non-coding RNA loci required for differentiation and pluripotency JR Haswell, K Mattioli, C Gerhardinger, PG Maass, DJ Foster, P Peinado, ... PLoS One 16 (11), e0252848, 2021 | 14 | 2021 |
| Combating castration-resistant prostate cancer by co-targeting the epigenetic regulators EZH2 and HDAC AE Schade, R Kuzmickas, CL Rodriguez, K Mattioli, M Enos, A Gardner, ... PLoS Biology 21 (4), e3002038, 2023 | 8 | 2023 |
| Resolving mechanisms of immune‐mediated disease in primary CD 4 T cells. EMBO Mol Med 12: e12112 C Bourges, AF Groff, OS Burren, C Gerhardinger, K Mattioli, A Hutchinson, ... | 4 | 2020 |
| Systematic characterization of regulatory variants of blood pressure genes W Oliveros, K Delfosse, DF Lato, K Kiriakopulos, M Mokhtaridoost, A Said, ... Cell Genomics 3 (7), 2023 | 3 | 2023 |
| Whole genome sequencing delineates regulatory and novel genic variants in childhood cardiomyopathy R Lesurf, A Said, O Akinrinade, J Breckpot, K Delfosse, T Liu, R Yao, ... MedRxiv, 2020.10. 12.20211474, 2020 | 2 | 2020 |
| Widespread variation in molecular interactions and regulatory properties among transcription factor isoforms L Lambourne, K Mattioli, C Santoso, G Sheynkman, S Inukai, B Kaundal, ... bioRxiv, 2024.03. 12.584681, 2024 | | 2024 |
| Abstract P4-08-11: AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution A Schade, N Perurena, M Watanabe, CL Rodriguez, P Loi, N Pilla, ... Cancer Research 83 (5_Supplement), P4-08-11-P4-08-11, 2023 | | 2023 |
| High-throughput characterization of lncRNA regulation, evolution, and function KM Mattioli Harvard University, 2019 | | 2019 |
